Mark E. Kleinman
- Genetics top 1%
- Cancer Research top 2%
- Rehabilitation top 2%
- Ophthalmology top 2%
- Retinal Diseases and Treatments 12
- Immunology top 5%
-
- Retinal Development and Disorders 8
- RNA regulation and disease 4
- Histone Deacetylase Inhibitors Research 4
- Angiogenesis and VEGF in Cancer 3
-
- Vascular Malformations and Hemangiomas 4
-
- Lysosomal Storage Disorders Research 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Co-authors
- Geoffrey C. GurtnerOren M. TepperRobert D. GalianoJennifer M. CaplaMatthew J. CallaghanDaniel J. CeradiniJamie P. LevineNicholas Bastidas
- Journals
- Investigative Ophthalmology & Visual Science (5 papers)Molecular Therapy (2 papers)Advances in experimental medicine and biology (2 papers)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Mark E. Kleinman
31 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Genetics 685
- Cancer Research 733
- Rehabilitation 204
- Ophthalmology 250
- Immunology 564
Countries citing papers authored by Mark E. Kleinman
This map shows the geographic impact of Mark E. Kleinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Kleinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Kleinman more than expected).
Fields of papers citing papers by Mark E. Kleinman
This network shows the impact of papers produced by Mark E. Kleinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Kleinman. The network helps show where Mark E. Kleinman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Kleinman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 12 | |
| 3 | 2020 | 23 | |
| 4 | 2020 | 3 | |
| 5 | Safety and efficiency of CRISPR-Cas9 gene editing in the retinal pigment epithelium | 2017 | 1 |
| 6 | 2015 | 70 | |
| 7 | 2015 | 7 | |
| 8 | Histone Deacetylase Expression and Inhibition in Age Related Macular Degeneration | 2014 | 1 |
| 9 | Enhanced Alu RNA stability due to iron-mediated DICER1 impairment causes NLRP3 inflammasome priming | 2014 | 1 |
| 10 | Epigenetic Regulation of Eotaxin Expression in Human Retinal Pigment Epithelium | 2013 | 1 |
| 11 | Dicer Dysregulation Induces Cytotoxic Alu Rna Accumulation In Age-related Macular Degeneration | 2011 | 1 |
| 12 | 2011 | 5 | |
| 13 | 2011 | 77 | |
| 14 | 2010 | 23 | |
| 15 | 2009 | 120 | |
| 16 | 2006 | 27 | |
| 17 | 2005 | 18 | |
| 18 | Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1breakdown → | 2004 | 2120 |
| 19 | 2003 | 67 | |
| 20 | 2003 | 46 |
About Mark E. Kleinman
Mark E. Kleinman is a scholar working on Ophthalmology, Neurology, Molecular Biology, Immunology and Genetics, having authored 31 papers that have together received 3.3k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (12 papers), Retinal Development and Disorders (8 papers), RNA regulation and disease (4 papers), Vascular Malformations and Hemangiomas (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Lysosomal Storage Disorders Research (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Genetics (685 citations), Cancer Research (733 citations), Rehabilitation (204 citations), Ophthalmology (250 citations) and Immunology (564 citations). Mark E. Kleinman has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Geoffrey C. Gurtner, Oren M. Tepper, Robert D. Galiano, Jennifer M. Capla, Matthew J. Callaghan, Daniel J. Ceradini, Jamie P. Levine, Nicholas Bastidas, Anita R. Kulkarni and Daniel J. Ceradini. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Molecular Therapy, Advances in experimental medicine and biology, Proceedings of the National Academy of Sciences and Lymphatic Research and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.